What is Field Trip Health Ltd. (FTRP)?

Field Trip Health Ltd. (FTRP) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of FTRP?

The current price of FTRP is $0.84. Prices are updated in real time on Stocks360.

What is FTRP's price-to-earnings (PE) ratio?

FTRP's trailing twelve-month PE ratio is -0.14, based on current price and earnings per share data available on Stocks360.

What is FTRP's market capitalization?

FTRP's market capitalization is $9,806,423.00, placing it in the small-cap tier.

Field Trip Health Ltd. (FTRP)

Stock analysis · NASDAQ · Healthcare · Medical - Care Facilities

$0.84

Market Cap

$9.81M

PE (TTM)

-0.14

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.00

Day Range

$0.81 – $0.85

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

163.87K

Field Trip Health Ltd. (FTRP) is a publicly traded company in the Healthcare sector. Latest price: $0.84. Market cap $9.81M. Trailing PE -0.14. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 15, 2022

EPS $-0.23 vs est. $-1.00

Beat by $0.77

Proprietary Signals

Signal snapshot temporarily unavailable.

About Field Trip Health Ltd.

Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.14×
P/S (TTM)	2.81×
P/B	0.12×
PEG	0.01×
P/FCF (TTM)	-0.29×
EV / EBITDA	-0.02×
EV / Sales	-4.32×
Earnings Yield	-718.58%
Free Cash Flow Yield	-350.33%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$21.00M
Net Income (TTM)	-$98.22M
Free Cash Flow (TTM)	-$46.77M
Net Debt	-$34.67M
Working Capital	$60.75M
Gross Margin	-88.27%
Operating Margin	-1102.78%
Net Margin	-1147.88%
Return on Equity	-61.81%
Return on Invested Capital	-55.82%